This findings is consistent with previous reports by other groups, showing differential expression ACTN1, FLNA, LPP, HSPB1, IL6, PLCB2, PTGS2, and SPP1 [28, 29], as well as SPP1 between AAA patients and control aortas [29]. The gene discussed is PLCB2; the disease is triple-A syndrome.